FDA Approves RHA Dynamic Volume for Midface Augmentation — New Competitor Enters Structural Filler Market

RHA Dynamic Volume is a resilient hyaluronic acid filler engineered to move naturally with facial expressions, unlike traditional cross-linked fillers. This dynamic formulation makes it a structural alternative to established brands like Restylane and Juvéderm, particularly for midface augmentation where natural movement is desired.

The FDA cleared RHA Dynamic Volume for correction of midface contour deficiencies and age-related volume loss. This approval positions it as a viable option in the high-volume midface market alongside existing filler competitors.

No, RHA Dynamic Volume is made by Revance, a separate manufacturer entering the structural filler market. This gives medspa owners a third major filler option beyond Allergan and Galderma's existing product lines.

RHA Dynamic Volume moves with facial expressions, creating more natural-looking results compared to traditional cross-linked fillers that remain static. This dynamic movement appeals to patients seeking subtle, expression-compatible augmentation in the midface.

Adding RHA Dynamic Volume gives practices a differentiated offering in the competitive midface market and provides patients with a dynamic alternative to established brands. The decision depends on your patient demand for natural movement and your existing filler inventory strategy.